Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAALAD2 | Q9Y3Q0 | 4/20 | 0.77 |
| ▸ | FOLH1 | Q04609 | 14/20 | 0.73 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.60 |
| ▸ | FPR2 | P25090 | 3/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11936648 | 1.00 | NAALAD2 (0.77) | NAALAD2FOLH1RIMKLAFPR2 | |
| SCHEMBL4317843 | 1.00 | NAALAD2 (0.77) | NAALAD2FOLH1RIMKLAFPR2 | |
| SCHEMBL4317844 | 1.00 | NAALAD2 (0.77) | NAALAD2FOLH1RIMKLAFPR2 | |
| SCHEMBL21992138 | 0.89 | FOLH1 (0.67) | NAALAD2FOLH1RIMKLA | |
| SCHEMBL11941364 | 0.88 | NAALAD2 (0.61) | NAALAD2FOLH1FPR2 | |
| SCHEMBL11984631 | 0.88 | FOLH1 (0.64) | NAALAD2FOLH1RIMKLA | |
| SCHEMBL9965331 | 0.87 | NAALAD2 (1.00) | NAALAD2FOLH1RIMKLA | |
| SCHEMBL13515316 | 0.87 | NAALAD2 (1.00) | NAALAD2FOLH1RIMKLA | |
| SCHEMBL4316981 | 0.87 | NAALAD2 (1.00) | NAALAD2FOLH1RIMKLA | |
| SCHEMBL11936623 | 0.87 | NAALAD2 (1.00) | NAALAD2FOLH1RIMKLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150079001-A1 | IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OR PSMA | THE JOHNS HOPKINS UNIVERSITY (US) | 2015-03-19 | — | — | US | claimed |
| US-20120276007-A1 | IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OR PSMA | GEORGETOWN UNIVERSITY (US) | 2012-11-01 | — | — | US | claimed |
| US-20090117042-A1 | Imaging agents and methods of imaging NAALADase or PSMA | THE JOHNS HOPKINS UNIVERSITY (US) | 2009-05-07 | — | — | US | claimed |
| EP-1472541-A1 | IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OF PSMA | The Johns Hopkins University (US) | 2004-11-03 | — | — | EP | claimed |
| US-20040054190-A1 | Imaging prostate cancer | JOHNS HOPKINS UNIVERSITY | 2004-03-18 | — | — | US | claimed |
| WO-2003060523-A1 | IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OF PSMA | JOHNS HOPKINS UNIVERSITY (US) | 2003-07-24 | — | — | WO | claimed |
| US-12534429-B2 | Heterodimers of glutamic acid | MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) | 2026-01-27 | — | — | US | disclosed |
| US-20230095637-A1 | Heterodimers of Glutamic Acid | CITIZENS BANK, N.A. | 2023-03-30 | — | — | US | disclosed |
| EP-4023624-A1 | HETERODIMERS OF GLUTAMIC ACID | Molecular Insight Pharmaceuticals, Inc. (US) | 2022-07-06 | — | — | EP | disclosed |
| EP-3699162-B1 | HETERODIMERS OF GLUTAMIC ACID | MOLECULAR INSIGHT PHARM INC (US) | 2022-06-29 | — | — | EP | disclosed |
| US-20210246103-A1 | HETERODIMERS OF GLUTAMIC ACID | CITIZENS BANK, N.A. | 2021-08-12 | — | — | US | disclosed |
| US-20210070696-A1 | HETERODIMERS OF GLUTAMIC ACID | MOLECULAR INSIGHT PHARMACEUTICALS, INC. | 2021-03-11 | — | — | US | disclosed |
| US-20210070695-A1 | HETERODIMERS OF GLUTAMIC ACID | MOLECULAR INSIGHT PHARMACEUTICALS, INC. | 2021-03-11 | — | — | US | disclosed |
| US-8227634-B2 | Imaging agents and methods of imaging NAALADase or PSMA | POMPER MARTIN GILBERT (US) | 2012-07-24 | — | — | US | disclosed |
| US-20090117042-A1 | Imaging agents and methods of imaging NAALADase or PSMA | THE JOHNS HOPKINS UNIVERSITY (US) | 2009-05-07 | — | — | US | disclosed |
| US-20080193381-A1 | HETERODIMERS OF GLUTAMIC ACID | MOLECULAR INSIGHT PHARMACEUTICALS, INC. | 2008-08-14 | — | — | US | disclosed |
| US-7408079-B2 | Imaging prostate cancer | THE JOHNS HOPKINS UNIVERSITY (US) | 2008-08-05 | — | — | US | disclosed |
| EP-1472541-A1 | IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OF PSMA | The Johns Hopkins University (US) | 2004-11-03 | — | — | EP | disclosed |
| US-20040054190-A1 | Imaging prostate cancer | JOHNS HOPKINS UNIVERSITY | 2004-03-18 | — | — | US | disclosed |
| WO-2003060523-A1 | IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OF PSMA | JOHNS HOPKINS UNIVERSITY (US) | 2003-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210070695-A1 | HETERODIMERS OF GLUTAMIC ACID | DDO, GLUL, ASNS | NAALAD2 7/4885FOLH1 5/4885RIMKLA 6/4885 |
| US-20040054190-A1 | Imaging prostate cancer | FOLH1, DUT, NAALAD2 | NAALAD2 3/4885FOLH1 1/4885RIMKLA 207/4885 |
| US-20090117042-A1 | Imaging agents and methods of imaging NAALADase or PSMA | FOLH1, DNPEP, NAALAD2 | NAALAD2 3/4885FOLH1 1/4885RIMKLA 197/4885 |
| US-20150079001-A1 | IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OR PSMA | FOLH1, DNPEP, NAALAD2 | NAALAD2 3/4885FOLH1 1/4885RIMKLA 197/4885 |
| US-12534429-B2 | Heterodimers of glutamic acid | FOLH1, GLUL, SLC25A13 | NAALAD2 15/4885FOLH1 1/4885RIMKLA 23/4885 |
| US-20080193381-A1 | HETERODIMERS OF GLUTAMIC ACID | DDO, GLUL, ASNS | NAALAD2 7/4885FOLH1 5/4885RIMKLA 6/4885 |
| US-20210070696-A1 | HETERODIMERS OF GLUTAMIC ACID | DDO, GLUL, ASNS | NAALAD2 7/4885FOLH1 5/4885RIMKLA 6/4885 |
| US-20120276007-A1 | IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OR PSMA | FOLH1, DNPEP, NAALAD2 | NAALAD2 3/4885FOLH1 1/4885RIMKLA 197/4885 |
| US-20230095637-A1 | Heterodimers of Glutamic Acid | DDO, GLUL, ASNS | NAALAD2 9/4885FOLH1 5/4885RIMKLA 6/4885 |
| US-20210246103-A1 | HETERODIMERS OF GLUTAMIC ACID | DDO, GLUL, ASNS | NAALAD2 7/4885FOLH1 5/4885RIMKLA 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.